The results showed that the combinatorial treatment of inv(16)/KITD816Y AML cells with the MTH1 inhibitor TH1579 and ROS-inducing agents could significantly increase DNA damage through the incorporation of oxidized nucleotides into DNA. Here, NUDT1 is linked to acute myeloid leukemia.